This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Apexigen, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Pia Björck: Innovator in Therapeutic Antibodies
Introduction
Pia Björck is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of therapeutic antibodies, particularly in the treatment of inflammatory and oncological diseases. Her work has the potential to impact many lives through innovative medical solutions.
Latest Patents
Pia holds a patent for "Anti-PD-L1 antibodies and methods of use." This patent includes anti-programmed death-ligand 1 (PD-L1) monoclonal antibodies and related compositions. These antibodies can be utilized in various therapeutic methods aimed at treating inflammatory and oncological diseases. Specifically, her patent features high affinity, humanized anti-PD-L1 antibodies.
Career Highlights
Pia is currently associated with Apexigen, Inc., where she continues to advance her research and development efforts. Her work at Apexigen focuses on creating innovative solutions in the field of immunotherapy.
Collaborations
Pia collaborates with talented professionals in her field, including Christine Tan and Erin Filbert. These partnerships enhance her research and contribute to the development of groundbreaking therapies.
Conclusion
Pia Björck is a dedicated inventor whose work in anti-PD-L1 antibodies showcases her commitment to improving therapeutic options for patients. Her contributions to the field of immunotherapy are invaluable and highlight the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile